Journal Article10.1038/310503A0
DARPP-32, a Dopamine-Regulated Neuronal Phosphoprotein, Is a Potent Inhibitor of Protein phosphatase-1
633
TL;DR: The basal ganglia of mammalian brain contain a region-specific neuronal phosphoprotein that is a protein phosphatase inhibitor, and like inhibitor-110, DARPP-32 is effective as an inhibitor in its phosphorylated but not its dephosphorylated form.
read more
Abstract: The neurotransmitter dopamine has been demonstrated by biochemical, histochemical and immunocytochemical techniques to be unevenly distributed in the mammalian central nervous system. DARPP-32 (dopamine- and cyclic-AMP-regulated phosphoprotein of molecular weight 32,000) is a neuronal phosphoprotein that displays a regional distribution in the mammalian brain very similar to that of dopamine-containing nerve terminals, being highly concentrated in the basal ganglia. The state of phosphorylation of DARPP-32 can be regulated by dopamine and by cyclic AMP in intact nerve cells, suggesting a role for this phosphoprotein in mediating certain of the effects of dopamine on dopaminoceptive cells. The observation that many of the physical and chemical properties of purified DARPP-32 resemble those of phosphatase inhibitor-1 (inhibitor-1), a widely distributed inhibitor of protein phosphatase-1, suggests that DARPP-32 might also function as a phosphatase inhibitor. We report here that DARPP-32 inhibits protein phosphatase-1 at nanomolar concentrations. Moreover, like inhibitor-1, DARPP-32 is effective as an inhibitor in its phosphorylated but not its dephosphorylated form. Thus, the basal ganglia of mammalian brain contain a region-specific neuronal phosphoprotein that is a protein phosphatase inhibitor.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
TL;DR: D dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms are discussed.
2.6K
The neurobiology of slow synaptic transmission.
TL;DR: Nerve cells communicate with each other through two mechanisms, referred to as fast and slow synaptic transmission, which control the efficacy of fast synaptic transmission by regulates the efficiency of neurotransmitter release from presynaptic terminals and by regulating the efficiency with which fast-acting neurotransmitters produce their effects on postsynaptic receptors.
928
Dopamine receptor signaling.
TL;DR: The D1-like and D2-like classes of dopamine receptors each has shared signaling properties that contribute to the definition of the receptor class, although some differences among subtypes within a class have been identified.
877
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Barbara Picconi,Diego Centonze,K Hakansson,Giorgio Bernardi,Paul Greengard,Gilberto Fisone,Gilberto Fisone,M. Angela Cenci,Paolo Calabresi +8 more
TL;DR: Results indicate that abnormal information storage in corticostriatal synapses is linked with the development of L-DOPA–induced dyskinesia.
849
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Marianne O. Klein,Daniella S. Battagello,Ariel R. Cardoso,David N. Hauser,Jackson C. Bittencourt,Ricardo G. Correa +5 more
TL;DR: The aspects of dopamine as a catecholaminergic neurotransmitter and dopamine signaling pathways elicited through dopamine receptor activation in normal brain function are summarized and the potential involvement of these signaling pathways in evoking the onset and progression of some diseases in the nervous system are described.
789
References
•Book
Protein phosphorylation in the nervous system
Eric J. Nestler,Paul Greengard +1 more
- 01 Jan 1984
TL;DR: Direct Evidence for a Role of Protein Phosphorylation in Neuronal Function and Applications of ProteinPhosphorylated Systems to Other Areas of Neuroscience are presented.
The Regulation of Glycogen Metaabolism
Gilllian A. Nimmo,Philip Cohen +1 more
TL;DR: The purified protein was in a state approaching homogeneity as judged by the criteria of polyacrylamide-gel electrophoresis and ultracentrifugal analysis, and amino acid composition suggest than inhibitor-1 may possess little ordered structure.
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization
TL;DR: Immunocytochemical studies indicate that DARPP-32, is present in the subclass of dopaminoceptive neurons containing D-1 receptors (dopamine receptors coupled to adenylate cyclase) and may be an effective marker for certain of the actions of dopamine that are mediated through cAMP and its associated protein kinase.
Protein phosphatases: properties and role in cellular regulation
TL;DR: The properties, physiological roles, and mechanisms for regulating the four protein phosphatases are reviewed and their roles in controlling glycogen metabolism, glycolysis, gluconeogenesis, fatty acid synthesis, cholesterol synthesis, and protein synthesis are reviewed.
Complete primary structure of protein phosphatase inhibitor-1 from rabbit skeletal muscle.
TL;DR: The complete primary structure of protein phosphatase inhibitor-1 has been determined and Serine-67 is substantially phosphorylated in vivo, but this phosphoserine residue does not appear to influence the activity of inhibitors-1.